Inge Jedema

8PUBLICATIONS
52CO-AUTHORS
Gene and molecular therapyMolecular targetsProteins and peptidesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 18, 2026
Phenotypic and Functional Characteristics of CD8+ T cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma.

|Aug 05, 2025
Publisher Correction: Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial.

Jessica S W Borgers, Divya Lenkala, Victoria Kohler

|Jan 14, 2025
Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies.

Thomas Kuilman, Deborah S Schrikkema, Jules Gadiot

|Jan 03, 2025
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial.

Jessica S W Borgers, Divya Lenkala, Victoria Kohler

|Nov 28, 2022
Human T cells recognize HLA-DP-bound peptides in two orientations.

Sebastian Klobuch, Jia Jia Lim, Peter van Balen

|Sep 19, 2022
Tracking the progeny of adoptively transferred virus-specific T cells in patients posttransplant using TCR sequencing.

W Huisman, M C J Roex, L Hageman

Pageof 2

Frequent Collaborators

4 joint publications

John Haanen

4 joint publications

Sebastian Klobuch

3 joint publications

Peter van Balen

2 joint publications

Matthijs D Linssen